A carregar...
Omalizumab usage in chronic urticaria and atopic dermatitis: data from South-East province of Turkey
INTRODUCTION: Omalizumab is a current treatment option for IgE-associated dermatoses, such as urticaria and atopic dermatitis. AIM: To evaluate the clinical and laboratory findings of patients with chronic urticaria and atopic dermatitis who received omalizumab. MATERIAL AND METHODS: This study was...
Na minha lista:
| Publicado no: | Postepy Dermatol Alergol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Termedia Publishing House
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6986296/ https://ncbi.nlm.nih.gov/pubmed/31998003 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/ada.2019.91424 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|